Organotin Polymers as Antiviral Agents Including Inhibition of Zika and Vaccinia Viruses

[1]  D. Chikobvu,et al.  Determinants of viral load rebound on HIV/AIDS patients receiving antiretroviral therapy: results from South Africa , 2018, Theoretical Biology and Medical Modelling.

[2]  M. Roner,et al.  Synthesis of Organotin Polyesters from Reaction of the Salt of d-Camphoric Acid and Organotin Dihalides and Initial Anticancer Activity , 2018, Journal of Inorganic and Organometallic Polymers and Materials.

[3]  A. Antinori,et al.  Nucleoside reverse transcriptase inhibitor‐reducing strategies in HIV treatment: assessing the evidence , 2018, HIV medicine.

[4]  C. Carraher.  Carraher's Polymer Chemistry , 2017 .

[5]  Michael E. Woolley,et al.  Zika virus: History, epidemiology, transmission, and clinical presentation , 2017, Journal of Neuroimmunology.

[6]  B. Mishra,et al.  Preparation and characterization of isoniazid and lamivudine co-loaded polymeric microspheres , 2016, Artificial cells, nanomedicine, and biotechnology.

[7]  M. Roner,et al.  Synthesis and Structural and Initial Cancer Cell Line Characterization of Organotin Polyesters from Dipicolinic Acid , 2016, Journal of Inorganic and Organometallic Polymers and Materials.

[8]  J. Martinez-Picado,et al.  Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions , 2016, Front. Pharmacol..

[9]  C. Katlama,et al.  Comparative risk of failure of ABC/3TC or TDF/FTC based first‐line regimens in patients with a high viral load , 2016, HIV medicine.

[10]  M. Roner,et al.  Synthesis and Preliminary Cancer Cell Line Results for the Product of Organotin Dihalides and Alpha-Cyano-4-Hydroxycinnamic Acid , 2016, Journal of Inorganic and Organometallic Polymers and Materials.

[11]  J. Olalla,et al.  Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[12]  M. Roner,et al.  Ability of simple organotin polyethers to inhibit pancreatic cancer , 2016 .

[13]  M. Azad,et al.  Botanical and phyto-pharmacological reports on Stephania japhonica , 2016 .

[14]  M. Roner,et al.  Control of Breast Cancer Using Organotin Polymers , 2015 .

[15]  M. Roner,et al.  Control of Prostate Cancer Using Organotin Polymers , 2015, Journal of Inorganic and Organometallic Polymers and Materials.

[16]  M. Roner,et al.  Control of colorectal cancer using organotin polymers , 2014 .

[17]  M. Roner,et al.  Organotin Polymers as Anticancer and Antiviral Agents , 2014 .

[18]  P. Verardi,et al.  A vaccinia virus renaissance , 2012, Human vaccines & immunotherapeutics.

[19]  M. Roner,et al.  Antiviral Activity of Metal-Containing Polymers—Organotin and Cisplatin-Like Polymers , 2011, Materials.

[20]  C. Carraher.  Introduction to Polymer Chemistry , 2010 .

[21]  Geoffrey L. Smith,et al.  Vaccinia virus morphogenesis and dissemination. , 2008, Trends in microbiology.

[22]  M. Roner,et al.  Synthesis, Structural Characterization, and Initial Evaluation as Anticancer Drugs of Dibutyltin Polyamines Derived from Various 4,6-Diaminopyrimidines , 2007 .

[23]  M. Roner,et al.  Synthesis, Structural Characterization, and Ability to Inhibit Cancer Growth of a Series of Organotin Poly(ethylene glycols) , 2007 .

[24]  M. Roner,et al.  Synthesis of Organotin Polyamine Ethers Containing Acyclovir and their Preliminary Anticancer and Antiviral Activity , 2006, Journal of inorganic and organometallic polymers and materials.

[25]  Joklik Wk.  Virus synthesis and replication: reovirus vs. vaccinia virus. , 1980 .

[26]  Paul W. Morgan,et al.  Condensation polymers: by interfacial and solution methods , 1965 .